Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.

[1]  J. Altman,et al.  MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.

[2]  A. Abu-Khader,et al.  Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation ‐ a comparison of different assays for the detection of cytomegalovirus‐specific T cells , 2013, European journal of haematology.

[3]  E. Mischak-Weissinger,et al.  CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  S. Exler,et al.  The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  S. Stevanović,et al.  Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Blasczyk,et al.  Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes. , 2012, International immunology.

[7]  J. Teruya-Feldstein,et al.  Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation. , 2012, Blood.

[8]  J. P. Houchins,et al.  Combining ELISPOT and ELISA to measure amounts of cytokines secreted by a single cell. , 2012, Methods in molecular biology.

[9]  R. Blasczyk,et al.  Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies , 2011, Journal of Translational Medicine.

[10]  A. Ganser,et al.  Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation , 2011, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  D. Busch,et al.  Adoptive transfer and selective reconstitution of streptamer‐selected cytomegalovirus‐specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation , 2011, Transfusion.

[12]  S. Mackinnon,et al.  Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  H. Einsele,et al.  Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. , 2010, Blood.

[14]  A. Gatti,et al.  Search for Anti-EA(D) Antibodies in Subjects with an “Isolated VCA IgG” Pattern , 2010, International journal of microbiology.

[15]  J. Stoltz,et al.  Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy , 2010, Journal of immunotherapy.

[16]  G. Ledderose,et al.  Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells. , 2010, Blood.

[17]  R. Pass,et al.  Enzyme-Linked Immunosorbent Assay for Measurement of Cytomegalovirus Glycoprotein B Antibody in Serum , 2010, Clinical and Vaccine Immunology.

[18]  Ann M Leen,et al.  Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation , 2010, Expert opinion on biological therapy.

[19]  H. Heuft,et al.  Soluble Recombinant CMVpp65 Spanning Multiple HLA Alleles for Reconstitution of Antiviral CD4+ and CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation , 2010, Journal of immunotherapy.

[20]  M. Freund,et al.  Multimer technologies for detection and adoptive transfer of antigen-specific T cells , 2010, Cancer Immunology, Immunotherapy.

[21]  Z. Berneman,et al.  Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays. , 2009, Journal of immunological methods.

[22]  C. Rinaldo,et al.  Multiple T-Cell Responses to Human Immunodeficiency Virus Type 1 Are Enhanced by Dendritic Cells , 2009, Clinical and Vaccine Immunology.

[23]  J. Castillo,et al.  Infectious Agents and Cancer Open Access Ebv-positive Diffuse Large B-cell Lymphoma in a Human T-lymphotropic Virus Type 1 Carrier , 2009 .

[24]  M. John,et al.  Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. , 2009, Journal of immunological methods.

[25]  K. Lucas,et al.  Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[26]  D. Lilleri,et al.  Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection , 2008, Haematologica.

[27]  H. Einsele,et al.  CMV-specific T cell therapy. , 2008, Blood cells, molecules & diseases.

[28]  J. Lowenthal,et al.  ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chicken. , 2008, Developmental and comparative immunology.

[29]  H. Heslop,et al.  Adoptive cellular immunotherapy for viral diseases , 2008, Bone Marrow Transplantation.

[30]  R. Blasczyk,et al.  Bioinformatic integration of biomechanics makes HLA sequencing universally applicable. , 2007, Tissue antigens.

[31]  F. Marincola,et al.  CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects , 2007, Journal of Translational Medicine.

[32]  C. Rooney,et al.  Adoptive immunotherapy for herpesviruses. , 2007 .

[33]  T. Lion,et al.  Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation , 2006, British journal of haematology.

[34]  A. Rickinson,et al.  CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells , 2005, The Journal of experimental medicine.

[35]  R. Handgretinger,et al.  Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation , 2005, British journal of haematology.

[36]  Elizabeth Sinclair,et al.  Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. , 2003, Journal of immunological methods.

[37]  M. Villacres,et al.  Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles. , 2003, Human immunology.

[38]  J. Altman,et al.  MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.

[39]  M. Hudgens,et al.  Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. , 2003, The Journal of infectious diseases.

[40]  S. Rowland-Jones,et al.  Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. , 2002, Blood.

[41]  P. Ott,et al.  Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes , 2002, Diabetes/metabolism research and reviews.

[42]  D. Busch,et al.  Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer , 2002, Nature Medicine.

[43]  Hans-Georg Rammensee,et al.  Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.

[44]  E. Thiel,et al.  Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. , 2001, Journal of immunological methods.

[45]  J. Wagner,et al.  Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. , 2000, Blood.

[46]  B. Boehm,et al.  Direct Visualization of Cytokine-Producing Recall Antigen-Specific CD4 Memory T Cells in Healthy Individuals and HIV Patients1 , 2000, The Journal of Immunology.

[47]  T. Whiteside,et al.  Evaluation of the Modified ELISPOT Assay for Gamma Interferon Production in Cancer Patients Receiving Antitumor Vaccines , 2000, Clinical Diagnostic Laboratory Immunology.

[48]  J A Madrigal,et al.  Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. , 1999, Journal of immunology.

[49]  K. Fujii,et al.  Rapid Determination of Epstein-Barr Virus–Specific CD8+T-Cell Frequencies by Flow Cytometry , 1999 .

[50]  S. Rowland-Jones,et al.  A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. , 1999, Journal of immunology.

[51]  G. Ogg,et al.  Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.

[52]  X. Jin,et al.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.

[53]  A. Rickinson,et al.  Epitope focusing in the primary cytotoxic T cell response to Epstein- Barr virus and its relationship to T cell memory , 1996, The Journal of experimental medicine.

[54]  J. Levy,et al.  Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. , 1991, Clinical and experimental immunology.